Fulgent Genetics (FLGT) Short-term Investments (2016 - 2026)

Fulgent Genetics (FLGT) has 11 years of Short-term Investments data on file, last reported at $252.9 million in Q1 2026.

• Quarterly Short-term Investments changed 0.05% year-over-year to $252.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $252.9 million (changed 0.05% YoY) and the FY2025 annual result came in at $285.9 million, up 40.86% from the prior year.
• Short-term Investments retreated to $252.9 million in Q1 2026 per FLGT's latest filing, from $285.9 million in the prior quarter.
• The five-year high for Short-term Investments was $446.7 million in Q4 2022, with the low at $155.0 million in Q3 2024.
• Average Short-term Investments over 5 years is $301.0 million, with a median of $258.2 million recorded in 2025.
• Year-over-year, Short-term Investments surged 88.89% in 2023 and plunged 59.6% in 2024.
• Fulgent Genetics' Short-term Investments stood at $446.7 million in 2022, then declined by 26.87% to $326.7 million in 2023, then slumped by 37.87% to $203.0 million in 2024, then jumped by 40.86% to $285.9 million in 2025, then decreased by 11.54% to $252.9 million in 2026.
• Business Quant data shows FLGT's Short-term Investments at $252.9 million in Q1 2026, $285.9 million in Q4 2025, and $258.2 million in Q3 2025.